A61K36/738

Dermatological product
09814774 · 2017-11-14 · ·

An improved composition for alleviating and treating the condition of scarring is provided. The system is directed to a product or composition which includes a silicone compound as a delivery medium, to which an oil compound such as sea buckthorn oil as an antioxidant is added. The product is prepared by mixing the two ingredients.

Dermatological product
09814774 · 2017-11-14 · ·

An improved composition for alleviating and treating the condition of scarring is provided. The system is directed to a product or composition which includes a silicone compound as a delivery medium, to which an oil compound such as sea buckthorn oil as an antioxidant is added. The product is prepared by mixing the two ingredients.

Dermatological product
09814774 · 2017-11-14 · ·

An improved composition for alleviating and treating the condition of scarring is provided. The system is directed to a product or composition which includes a silicone compound as a delivery medium, to which an oil compound such as sea buckthorn oil as an antioxidant is added. The product is prepared by mixing the two ingredients.

Medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, preparation method therefor and use method thereof
20170319475 · 2017-11-09 ·

The present invention discloses a medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, a preparation method thereof and use methods thereof. The medicine comprises: lightyellow sophora root, glabrous greenbrier rhizome, bark of Chinese corktree, raw sessile stemona root, alumen, coptis root, cortex dictamni, chinaberry bark and root-bark, pangolin scales, amber, eucommia bark, tree peony bark, clematis root, common cnidium fruit, Chinese angelica, licorice root, common macrocarpium fruit, barbary wolfberry fruit, medicinal indianmulberry root, cherokee rose fruit, chinaroot greenbier rhizome, akebia fruit, milkvetch root, Japanese climbing fern spore, asiatic pennywort herb, mulberry leaf and frankincense. The present invention not only provides the medicine capable of effectively treating the acquired immunodeficiency syndrome, but also enables the medicine to be capable of being used in conjunction with other medical technical means to easily achieve a more ideal treatment effect.

Medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, preparation method therefor and use method thereof
20170319475 · 2017-11-09 ·

The present invention discloses a medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, a preparation method thereof and use methods thereof. The medicine comprises: lightyellow sophora root, glabrous greenbrier rhizome, bark of Chinese corktree, raw sessile stemona root, alumen, coptis root, cortex dictamni, chinaberry bark and root-bark, pangolin scales, amber, eucommia bark, tree peony bark, clematis root, common cnidium fruit, Chinese angelica, licorice root, common macrocarpium fruit, barbary wolfberry fruit, medicinal indianmulberry root, cherokee rose fruit, chinaroot greenbier rhizome, akebia fruit, milkvetch root, Japanese climbing fern spore, asiatic pennywort herb, mulberry leaf and frankincense. The present invention not only provides the medicine capable of effectively treating the acquired immunodeficiency syndrome, but also enables the medicine to be capable of being used in conjunction with other medical technical means to easily achieve a more ideal treatment effect.

Dietary supplement containing alkaline electrolyte buffers
09808441 · 2017-11-07 ·

An improved dietary and/or therapeutic supplement composition comprising a quantity of a dietary and/or therapeutic supplement agent having a pH that upon ingestion with food or a beverage would limit the effectiveness of the agent and a sufficient amount of an alkaline electrolyte additive is provided in combination with the agent to raise the pH of the composition to a level of from about 8 to about 12.5 to increase the effectiveness and functional utilization of the agent while the composition is in the person's stomach.

Dietary supplement containing alkaline electrolyte buffers
09808441 · 2017-11-07 ·

An improved dietary and/or therapeutic supplement composition comprising a quantity of a dietary and/or therapeutic supplement agent having a pH that upon ingestion with food or a beverage would limit the effectiveness of the agent and a sufficient amount of an alkaline electrolyte additive is provided in combination with the agent to raise the pH of the composition to a level of from about 8 to about 12.5 to increase the effectiveness and functional utilization of the agent while the composition is in the person's stomach.

COMPOSITIONS COMPRISING PLANT EXTRACTS AND OILS AND RELATED METHODS OF TREATMENT AND THEIR PREPARATION
20220233627 · 2022-07-28 ·

Disclosed are compositions comprising botanical extracts and cold-pressed oils and related methods of manufacture and methods of use for the treatment of skin conditions and diseases.

COMPOSITIONS COMPRISING PLANT EXTRACTS AND OILS AND RELATED METHODS OF TREATMENT AND THEIR PREPARATION
20220233627 · 2022-07-28 ·

Disclosed are compositions comprising botanical extracts and cold-pressed oils and related methods of manufacture and methods of use for the treatment of skin conditions and diseases.

COMPOSITIONS COMPRISING PLANT EXTRACTS AND OILS AND RELATED METHODS OF TREATMENT AND THEIR PREPARATION
20220233627 · 2022-07-28 ·

Disclosed are compositions comprising botanical extracts and cold-pressed oils and related methods of manufacture and methods of use for the treatment of skin conditions and diseases.